The Recall Desk
ModerateFDA (Devices)·Z-1890-2025·Announced 2025-06-11

FoundationOne Companion Diagnostic contains incorrect negative claims

Foundation Medicine is recalling two FoundationOne Companion Diagnostic (F1CDx) test reports that contained an incorrect negative claim on the claims page, though the device variant information displayed correctly in the tumor profiling section.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall involving a labeling or reporting error in a companion diagnostic test. The source states no illnesses or injuries were reported, and the critical tumor profiling information displayed correctly; the error was limited to an incorrect claim on the claims page, making this a moderate-severity labeling defect.

Plain-English summary

Foundation Medicine, Inc. is recalling two FoundationOne Companion Diagnostic (F1CDx) test reports distributed nationwide in Michigan. The recalled reports contained an incorrect negative claim displayed on the claims page of the FDA-approved test reports.

The device variant information was displayed correctly in the tumor profiling section of both affected reports. Customers received these reports with the incorrect claims page information. No further details regarding patient impact, corrective actions, or return procedures are specified in the available source material.

The recalled product

Product
FoundationOne Companion Diagnostic (F1CDx)
Manufacturer
Foundation Medicine, Inc.
Hazard
  • mis-labeling

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Report Numbers: ORD-XXXXX77-01

Distribution

Distributed nationwide across the United States.